PTK6 抗体
(PTK6 Protein tyrosine Kinase 6 (PTK6))
The protein encoded by this gene is a cytoplasmic nonreceptor protein kinase which may function as an intracellular signal transducer in epithelial tissues. Overexpression of this gene in mammary epithelial cells leads to sensitization of the cells to epidermal growth factor and results in a partially transformed phenotype. Expression of this gene has been detected at low levels in some breast tumors but not in normal breast tissue. The encoded protein has been shown to undergo autophosphorylation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| PTK6 抗体 (pTyr342) (Alexa Fluor 680) | 人 | 兔 Polyclonal |
|
|
|
| PTK6 抗体 (pTyr342) (Alexa Fluor 647) | 人 | 兔 Polyclonal |
|
|
|
| PTK6 抗体 (pTyr447) (Alexa Fluor 647) | 人 | 兔 Polyclonal |
|
|
|
| PTK6 抗体 (pTyr447) (Alexa Fluor 750) | 人 | 兔 Polyclonal |
|
|
|
| PTK6 抗体 (pTyr342) (Alexa Fluor 750) | 人 | 兔 Polyclonal |
|
|
|
| PTK6 抗体 (pTyr447) (Alexa Fluor 594) | 人 | 兔 Polyclonal |
|
|
|
| PTK6 抗体 (pTyr342) (Alexa Fluor 594) | 人 | 兔 Polyclonal |
|
|
|
| PTK6 抗体 (pTyr342) (Alexa Fluor 488) | 人 | 兔 Polyclonal |
|
|
|
| PTK6 抗体 (pTyr447) (Alexa Fluor 488) | 人 | 兔 Polyclonal |
|
|
|
| PTK6 抗体 | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| PTK6 抗体 (Center) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| PTK6 抗体 (pTyr447) | 人, 大鼠 | 兔 Polyclonal |
|
|
|
| PTK6 抗体 (pTyr342) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| PTK6 抗体 (N-Term) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| PTK6 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| PTK6 抗体 | 人 | 小鼠 Monoclonal |
|
|
Primary Antibody
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Alexa Fluor 680
- 抗原表位
- pTyr342
Primary Antibody
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Alexa Fluor 647
- 抗原表位
- pTyr342
Primary Antibody
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Alexa Fluor 647
- 抗原表位
- pTyr447
Primary Antibody
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Alexa Fluor 750
- 抗原表位
- pTyr447
Primary Antibody
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Alexa Fluor 750
- 抗原表位
- pTyr342
Primary Antibody
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Alexa Fluor 594
- 抗原表位
- pTyr447
Primary Antibody
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Alexa Fluor 594
- 抗原表位
- pTyr342
Primary Antibody
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Alexa Fluor 488
- 抗原表位
- pTyr342
Primary Antibody
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Alexa Fluor 488
- 抗原表位
- pTyr447
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Center
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- pTyr447
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- pTyr342
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 1-28, N-Term
Latest Publications for our PTK6 抗体
: "Overexpression of PTK6 predicts poor prognosis in bladder cancer patients." in: Journal of Cancer, Vol. 8, Issue 17, pp. 3464-3473, (2018) (PubMed).
: "The marine-derived sipholenol A-4-O-3',4'-dichlorobenzoate inhibits breast cancer growth and motility in vitro and in vivo through the suppression of Brk and FAK signaling." in: Marine drugs, Vol. 12, Issue 4, pp. 2282-304, (2014) (PubMed).
: "Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors." in: European journal of medicinal chemistry, Vol. 73, pp. 310-24, (2014) (PubMed).
: "Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma." in: Medical oncology (Northwood, London, England), Vol. 31, Issue 12, pp. 317, (2014) (PubMed).
: "Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models." in: PLoS ONE, Vol. 9, Issue 5, pp. e97622, (2014) (PubMed).
: "Marine natural products-inspired phenylmethylene hydantoins with potent in vitro and in vivo antitumor activities via suppression of Brk and FAK signaling." in: Organic & biomolecular chemistry, Vol. 12, Issue 28, pp. 5295-303, (2014) (PubMed).
: "Additive impact of HER2-/PTK6-RNAi on interactions with HER3 or IGF-1R leads to reduced breast cancer progression in vivo." in: Molecular oncology, Vol. 9, Issue 1, pp. 282-94, (2014) (PubMed).
: "Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma." in: Journal of translational medicine, Vol. 11, pp. 59, (2013) (PubMed).
: "Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells." in: Oncogene, Vol. 22, Issue 27, pp. 4212-20, (2003) (PubMed).
: "Sam68 enhances the cytoplasmic utilization of intron-containing RNA and is functionally regulated by the nuclear kinase Sik/BRK." in: Molecular and cellular biology, Vol. 23, Issue 1, pp. 92-103, (2002) (PubMed).
: "The marine-derived sipholenol A-4-O-3',4'-dichlorobenzoate inhibits breast cancer growth and motility in vitro and in vivo through the suppression of Brk and FAK signaling." in: Marine drugs, Vol. 12, Issue 4, pp. 2282-304, (2014) (PubMed).
: "Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors." in: European journal of medicinal chemistry, Vol. 73, pp. 310-24, (2014) (PubMed).
: "Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma." in: Medical oncology (Northwood, London, England), Vol. 31, Issue 12, pp. 317, (2014) (PubMed).
: "Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models." in: PLoS ONE, Vol. 9, Issue 5, pp. e97622, (2014) (PubMed).
: "Marine natural products-inspired phenylmethylene hydantoins with potent in vitro and in vivo antitumor activities via suppression of Brk and FAK signaling." in: Organic & biomolecular chemistry, Vol. 12, Issue 28, pp. 5295-303, (2014) (PubMed).
: "Additive impact of HER2-/PTK6-RNAi on interactions with HER3 or IGF-1R leads to reduced breast cancer progression in vivo." in: Molecular oncology, Vol. 9, Issue 1, pp. 282-94, (2014) (PubMed).
: "Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma." in: Journal of translational medicine, Vol. 11, pp. 59, (2013) (PubMed).
: "Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells." in: Oncogene, Vol. 22, Issue 27, pp. 4212-20, (2003) (PubMed).
: "Sam68 enhances the cytoplasmic utilization of intron-containing RNA and is functionally regulated by the nuclear kinase Sik/BRK." in: Molecular and cellular biology, Vol. 23, Issue 1, pp. 92-103, (2002) (PubMed).
Aliases for PTK6 抗体
protein tyrosine kinase 6 (PTK6) 抗体PTK6 protein tyrosine kinase 6 (Ptk6) 抗体
protein tyrosine kinase 6 (Ptk6) 抗体
PTK6 protein tyrosine kinase 6b (ptk6b) 抗体
BRK 抗体
Sik 抗体
tks 抗体
Tksk 抗体
zgc:153964 抗体
您还需要查找其他产品吗？
You are here:
